Background In the UK, altruism has featured explicitly as an underpinning principle for biobanking. However, conceptualizing donation as altruistic downplays the role of reciprocity and personal or family benefit.
Introduction
Biobanking, governance and consent
In 1999, a UK public inquiry followed the discovery that a pathologist at Liverpool's Alder Hey children's hospital had retained organs for research without parental consent. This led to the UK Human Tissue Act 2004 and the regulatory Human Tissue Authority from 2006. Media analysis suggests that reporting of such incidents created a climate of public horror, with images of fragmented bodies and 'stolen hearts' 1 (p 38-39):
The organ retention scandal was exceptionally powerful in its designation of villains, victims, heroes, and its organization of the 'proper' responses to events and actions, in particular by polarizing the interests of the medical/scientific community and the lay community. . ... Politicians during the scandal aimed to align themselves with the apparent victims, and were notable for their unwillingness to defend the medical agenda and their readiness to take the part of presumed 'public opinion' as it appeared to them to be represented in media reports.
Such reporting presumes that all body parts are special and that suspicion of and resistance to using human tissue in medical research are widespread. In bioethics and social science literatures, a discourse of 'social unease' about biosamples has predominated, 2 in which bodily integrity, dignity, personhood and autonomy are set against a rising tide of commodification and capitalist exploitation. 3 The issue is further complicated by developments in genetics and increasingly widespread storage of DNA samples, generating public concerns about a surveillance society, and other fears such as genetic manipulation and cloning. [8] [9] [10] Biobanks are repositories of biosamples, which are used to conduct research into the prevention, diagnosis and treatment of a range of diseases. The question of biobank regulation and the relationship between donors and research has generated much ethical and sociolegal debate. [11] [12] [13] [14] [15] This fits within a wider literature around trust and the feasibility (or not) of fully informed consent. 16 This particularly affects biobanking given the long-term nature of sample storage and the difficulty of anticipating every possible future use, coupled with growing pressure from funders to share research data as a public good. 17 However, much of this is either theoretical debate or single legal case analysis rather than empirical work to gauge how far 'social unease' really represents public views. 2 19 of the attitudes of parents, whose children have cancer, to tissue samples as 'gifts'. They found that the blood donation 'gift' model did not match families' views, and the samples were not valued by the donors. Parents consented on condition there was no risk, pain, or inconvenience to their child. Using the term 'gift' appeared troublingrather than persuading family members to consent, it provoked some discomfort, and even offence. Thus, the term 'gift' could undermine rather than secure the co-operation of potential donors. However, these family accounts did demonstrate some key features of Titmuss's 6 'gift relationship', particularly tissue banking as a means of affirming social solidarity with a welldefined childhood cancer 'illness community'. Consent was directed towards helping others in the interests of common (rather than individual) good, without expecting reward.
We build on Dixon-Woods and colleagues' study 19 by asking biobanking participants explicitly about their attitudes to biosamples as gifts and add to the evidence in several ways. Firstly, we examine the responses of selfconsenting adults, rather than parents consenting for their children. Secondly, we assess the responses of healthy volunteers and people affected by a wider range of conditions. Finally, we explore how people feel about different types of sample (including urine, blood and tumour samples).
Methods

Sample and recruitment
Twenty-one people were recruited who had given biosamples for research or had been invited and declined. Some had given samples more than once or had consented on one occasion but declined on another. One had declined the only time he was asked (for a population biobank). All were white British. Some were recruited for us by researchers at specific biobanks; others came from media advertising, snowballing or word of mouth. The sample included both healthy volunteers and people with a health condition (see Table 1 ). Interview transcripts were first coded (by AMB) using NVIVO software and an initial coding framework developed by both authors in discussion. This included the full range of anticipated and emergent themes (e.g. recruitment and information, deciding whether to donate, experiences of actual donation, feedback and communication) and was refined through constant comparison. We reflected on specific comments about the differential value of samples in response to questions about type of donation (especially tumour, urine and blood). We also reflected on the links between attitudes to samples and whether or not the person was healthy or had an illness. For this paper, we jointly analysed in more detail the range of perspectives expressed within the codes relating to reasons for participating, and attitudes to the term 'gift', paying particular attention to use of language. Wider findings are available on the health information Website healthtalk.org.
Results
General reasons for taking part
Before discussing responses regarding samples as gifts, we summarize people's motives for taking part in biobanking. Consistent with the literature, they gave a range of reasons. Compared to genetics research or clinical trials, biobanking offers fewer obvious familial or personal benefits, especially for healthy volunteers; not surprisingly, therefore, 'altruistic' or social motivations were commonly expressed. However, personal benefits were also noted, most commonly by people with an illness or condition, but also by healthy volunteers.
Reasons for taking part included aiding medical science; improving understanding and treatment of health and illness for future patients; gaining potential personal benefits (e.g. a free health check/information about one's health; obtaining better care; aiding the potential development of a cure for one's con- In addition to benefits reported as initial motivating factors, people later perceived other advantages which they said might encourage them to take part again, including the rapport and sense of partnership they enjoyed with researchers.
Many viewed the decision to take part in biobanking as less of a 'Why?' and more of a 'Why not?' Trust in UK research regulation was high and biosample donation was seen as unproblematic. Whilst some wanted to know how their sample would be protected, several said they had not read the information leaflets they were given because they were confident it would be appropriately handled by the researchers and safeguarded by regulations.
Biosamples as gifts
We now present five original interpretations of biosamples as gifts: unreserved, reciprocal, collective, unwanted/low-value and exaggerated gift.
'Gift' as an appropriate term -the unreserved gift For most people interviewed, biobanking seemed simple to do; many were surprised or puzzled to think there was even a story to tell, let alone that anyone would be interested to hear it. Many said they had not considered their donation as a gift until explicitly questioned about it, a gift not routinely thought of as such, but for a few this resonated (see Box 1).
This view seemed more common amongst people with a specific health condition, perhaps reflecting the sense of an illness community (a shared sense of identity with others who experience the same illness) with future beneficiaries of the research. It is important also to note the point that a sample may be 'very easy to give', although in the case of the MND biobank taking part included an option to have a lumbar puncture to donate spinal fluid. Two of the four people interviewed with motor neurone disease (MND) had declined this element of the research as too invasive.
The last of the three quotations in Box 1 is interesting in the way the respondent moves from a question about a 'gift' to a more mundane verbal form, 'I've given it'. We return to this point later. Her remark 'It's something I can do' also relates to other points in her interview where she described research participation as a way of regaining control when faced by terminal illness, 'almost to get back at the disease'. As she explained:
The thought of just sitting, waiting for the disease to take over seemed very alien. And so I thought the only proactive thing that I could do about the disease was maybe to take part in any research.
Thus, whilst she perceived no direct health benefit, an alternative form of personal benefit is evident, in helping her make sense of a distressing situation.
A reciprocal gift
For some people, the notion of a direct relationship with past or future beneficiaries of health care and medical research was explicit, not just in terms of an illness community but also sometimes one's own family (see Box 2). One woman, who did not herself find the language of gift appropriate, nonetheless identified reciprocal exchange at the heart of her motivation. Her twin brother received a lot of care including (unsuccessful) experimental surgery. As a healthy donor to a diabetes biobank, she felt she was giving back on his behalf. Another woman recovering from breast cancer felt more at ease with the language of gift, even though it had not occurred to her before. It is significant that breast cancer can have a genetic component; the potential to help others in one's family may therefore temper the sense of altruism. Note, for example, the force of 'but' in the second extract in Box 2 -'there is no personal benefit to you at this time. But of course we all think about generations to come and our families' -implying that even if there is no personal benefit now there may be later in the form of familial benefit, alongside wider social benefit. Note also how her initial definition of a gift (because there is no personal benefit) reflects the interpretation of gift in policy documents cited in the introduction ('a gift free of all claims') rather than an anthropological exchange model.
A man with well-controlled hepatitis C virus who had often given blood and liver samples questioned the direction of the gift and highlighted the reciprocal importance of research which might develop a cure during his lifetime.
That's valuable time that's being spent on something very important. And it's probably as important to me as it is to the people doing the research. So who's getting the gift? Me, or them?
However, although he personally did not find it appropriate for what he described as 'tissue, odd bits, pints of blood' (see 'gift as exaggeration' below), he added, 'I can see "gift" might resonate with some people. I can't offhand think of a better term'.
Collective gift
One woman, musing on the difference between the kind of gift relationship involved in blood donation versus biosamples for research, used a comparison with the office whip-round. This was an isolated but intriguing conceptualization.
I suppose you could regard that [biobanking] more like a sort of collection for a gift or something, you know -a collection for a leaving gift or something in the office -rather than the personal gift. (Female healthy volunteer, population biobank) This is an interesting representation of the social distance between donor and recipient, suggesting both how the 'gift' in itself is worthless or of low value unless combined with others' contributions, and how this in turn undermines any sense of personal relationship with eventual beneficiaries, specifically unlike a blood donation which goes from one person straight to another.
Unwanted or low-value gift
As noted earlier, many people had never before considered donated biosamples as gifts. Many struggled to relate this idea to their own experience, often laughing or giving humorous replies. Consistent with the notion of a collective gift, where one's own contribution has little intrinsic value until combined with others, some people considered it at best a low-value or unwanted gift.
I don't regard that I'm giving it as a gift. Maybe a free gift? No, I don't think of it as a gift. (Female healthy volunteer to both a population and a diabetes biobank)
A woman who had contributed to a population biobank but also gave breast cancer tumour samples for research agreed with the Box 1 Biosamples as an unreserved gift I would say unequivocally, yes. It is, for me personally, a gift, and that's where I stand (Man with MND) Yes, it strikes a chord with me that when I give a sample or a donation it is like giving a gift, though it's one that I'm very happy to give, and in the case of an extra urine sample, for example, it's very, very easy to give (Woman who gave samples both as a healthy volunteer and during high-risk pregnancy) I suppose it is [a gift] in a sense, really. It's something I can do, and I feel I have no claim whatsoever over it, that I've given it (Woman with MND) idea of participation as a gift, but in relation to her tumour sample commented:
The alternative is it gets thrown away. Well, if somebody else can use it. . . You get Christmas gifts you don't want, so you recycle them through the charity shop or something. That's the same thing. I know that's perhaps trivializing it. But if somebody can get use out of it, why not?
'Gift' as an exaggeration Underlying many of these responses was a sense that the use of the word 'gift' was overstating the value of biosamples, an exaggeration some saw as faintly ridiculous. This view was particularly associated with tumour and urine samples, although for some people it applied equally to blood (see Box 3) .
Interestingly, the man with hepatitis C virus quoted in Box 3 went on to say of his donations, 'I suppose it's my philanthropic sideand that I've found surprisingly rare in other people, which has surprised me over the years'. Thus, 'philanthropy' resonated with him even if 'gift' did not.
However, others saw blood as something different. This may partly reflect the more invasive nature of donating blood samples, compared to something which is excreted or is being removed anyway. Perhaps more significantly, people often found it difficult to separate blood for research from therapeutic blood donation in their thinking, which in turn reveals the special significance attached to blood as a valuable and life-giving substance. This contrasts with waste products such as urine or a positively 'unwelcome invader' such as a tumour. An example of this way of thinking is given in Box 4.
The example in Box 4 brings us back to the use of language. Whilst the verbs 'give' and 'donate' were used readily in people's talk about biosamples, the noun 'gift' seems to imply something more special and deliberate, evoking an image of a gift-wrapped present. As one healthy volunteer commented, reminding us of the benefits she derived from participation:
To me giving a gift's sort of a bigger thing. . ..As I've said before, to me there were some benefits [laughs] because, you know, you were relaxing all day. . ..But I mean to me, giving -I mean you go to your GP and he could say, "Well, I need a blood sample." But you wouldn't say you were giving him a gift, would you?
Discussion and conclusions
We have explored people's thoughts about the concept of donating biosamples as 'gifts'. We found that attitudes to donation are ambiguous and this is consistent with previous research. 22 Participants cited several reasons for donating, often being motivated by multiple factors. The findings from our qualitative sample also accord with survey findings sug- I hadn't thought of it in those terms, but, yes, I think it is [a gift], because they're very keen to stress that there is no personal benefit to you at this time. But of course we all think about generations to come and our families, and I would hope that in some way it can contribute to better health and better diagnosis and treatment for family, you know, generations to come. (Woman who gave samples both as a healthy volunteer and during breast cancer treatment)
gesting that people may not find biosample donation as ethically troubling as some ethicists presume; for many the donation of 'waste' products (e.g. tumour or urine) evokes little concern, confirming previous findings that people trust research regulation and perceive few actual risks. 22 Equally, our conceptualization of reciprocal gifts and especially the collective gift adds weight to Widdows and Cordell's 33 notion of corporate goods, which go beyond individual benefits and reciprocity. Our participants acknowledge a value in donating even 'low-value/unwanted gifts' for our collective social good. For this study, it proved very difficult to recruit people from ethnic minority communities and also those who refused to take part in biobanking. As people who had consented to donate samples felt they had little to tell, those who declined would presumably find it even harder to see what they could contribute in an interview. We interviewed one man who declined primarily because of concerns about data protection. It would be valuable to have more perspectives from people who decline donation.
Our findings reveal a range of previously unexplored perspectives on the notion of biosamples as gifts. Consistent with Dixon-Woods et al.,
19 our more diverse sample of self-consenting adults indicates that the word itself resonates with some (especially those living with an illness), but not with others (both healthy volunteers and those living with an illness), and that all samples as gifts are not considered equal. However, this is generally not because they regard the sample as some intrinsically important part of themselves, rather it is seen as something minor and trivial; easy to give; something potentially benefitting themselves and others; and which affirms social solidarity through diffuse or asynchronous reciprocity. Even if they invoke concepts and language which could be seen as consistent with anthropological understandings of an exchange network, people are commonly sceptical of the actual word 'gift', seeing it as an overstatement, and tend to adopt a lay definition (similar to the biomedical discourse) of a 'gift free of all claims' without feeling they are creating obligations in return. Nor do they seem to expect any continuing relationship with the biobank. Bizzarely I think it's a bit of an honour, really. I wouldn't call it a gift. I don't think it is [um] -I mean if that's, if that hits some people's buttons, great. It's just a "why wouldn't you?" It's a more naturally "yes" thing than "no" thing (Woman, healthy volunteer)
If I'm sitting here and someone comes along and says, you know, "Give us a few phials of your blood because we might be able to do something with it", I'm just not going to think twice about it. It's not a gift (Man with MND) . . .the 'corporeal' economy of blood transfusion, in which the blood itself is of immense value and is used to assist someone in emergency medical need, with the informational economy of research, in which blood is merely an easy way of getting to the DNA.
This distinction resonates with our findings and helps explain why 'gift' can seem a troubling or inappropriate word for biosamples. The gift -the value -is in the giving, in the collective contribution to research, rather than in the sample itself. Focusing on the value of participation and the information derived rather than the value of the physical sample might have more intuitive appeal to potential participants. Perhaps this is not limited to biobanking, but could also be extended to other types of clinical research, including clinical trials.
Practical implications arising from this study are that we should avoid the term 'gift' in communicating with patients and seeking consent for donation, given that it holds such different meaning for different people and therefore offers little utility in representing participants' views. Governing bodies should exercise caution when setting discourses around donation, whilst recognizing that the public holds positive attitudes towards helping others and donating biosamples.
